The public's shift from mutual funds and ETFs towards speculating in individual stocks and options continues without pause. Last week's options volume boomed to a new record. All signs suggest the mania is making new peaks.... Read More
Jim was on Bloomberg TV this morning talking about the Fed and what they should do at the December FOMC meeting.... Read More
The outflows from funds should not be seen as the result of investors de-risking. Rather, investing styles and preferences are changing.... Read More
Despite the markets "living in the second half of 2021," signs are emerging that the next few quarters will be a struggle. Analysts are not as optimistic about the return to normal.... Read More
AstraZeneca's sold off on news of a new vaccine with 70% efficacy. However, this new vaccine has a couple advantages to those offered by Pfizer and Moderna in recent weeks.... Read More
While vaccine news has provided a positive breath recently, infection counts continue to climb across the world. The response between now and the time the vaccine is widely distributed will be critical.... Read More
As another earnings season comes to a close, companies have once again successfully guided analysts' expectations low enough to ensure positive results. This is a game that has been perfected over the past decade.... Read More
Foreigners sold their third largest monthly sum of corporates on record, unloading $26.99 billion in September and a record $127.65 billion over the past year.... Read More
A big part of bank/financial stock performance is tied to the outlook of interest rates, spreads (net interest margins), and the reason why rates are moving (growth or inflation). We understand why higher rates are considered good for banks for now. But when/if this view flips to a belief that inflation is returning, rising rates will no longer benefit banks.... Read More
The market is starting to see a Fed hike on the distant horizon. This is how a shift in thinking begins. The driving reason for this change seems to be a resurgence of inflation over booming real growth.... Read More
As COVID cases continue to spike, lockdowns are being instituted and the economy is struggling. But, for now, all that is being overlooked because a vaccine is coming.... Read More
Since the Fed began buying corporate bonds and bond ETFs, this sector trades more like an index and less like a market of bonds.... Read More
Good news on the vaccine front has ignited a powerful rally and a violent reversal away from work-from-home stocks. This is all good news. However, inflation and much higher interest rates now become a bigger risk worth monitoring.... Read More
